3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Squamous Cell Carcinoma of Head and Neck
2
Virus Diseases
1
Tumor Virus Infections
1
Pharyngeal Diseases
1
Papillomavirus Infections
1
Otorhinolaryngologic Neoplasms
1
Otorhinolaryngologic Diseases
1
Oropharyngeal Neoplasms
1
Neoplasms, Squamous Cell
1
Neoplasms, Glandular and Epithelial
1
Neoplasms by Site
1
Neoplasms by Histologic Type
1
Head and Neck Neoplasms
1
DNA Virus Infections
1
Carcinoma, Squamous Cell
1
Carcinoma
1
Interventions
Human Papillomavirus Recombinant Vaccine nonavalent
9
Papillomavirus Vaccines
8
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
8
Surveys and Questionnaires
6
Educational Status
6
Blood Specimen Collection
5
Vaginal Smears
4
Radiotherapy, Intensity-Modulated
4
Methods
4
Human Papillomavirus DNA Tests
4
Early Intervention, Educational
4
Cisplatin
4
Carboplatin
4
Patient Navigation
3
Mass Screening
3
Taxes
2
Standard of Care
2
Radiation
2
Practice Guidelines as Topic
2
Papanicolaou Test
2
Paclitaxel
2
Motivational Interviewing
2
Interviews as Topic
2
Electrocoagulation
2
Docetaxel
2
Cytological Techniques
2
Cryotherapy
2
Colposcopy
2
utomilumab
1
toripalimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Papillomavirus Infections
×
Nimorazole
×
Clear all
NCT04124198
2025-12-31
QoLATI
Rigshospitalet, Denmark
Phase NA
Active not recruiting
138 enrolled